Edward Stadtmauer

University of Pennsylvania, PA

Edward A.Stadtmauer, MD
Roseman, Tarte, Harrow and Schaffer Families
President’s Distinguished Professor
Perelman School of Medicine
University of Pennsylvania

Dr Stadtmauer is Chief of the Hematologic Malignancies Section within the Division of Hematology-Oncology, Department of Medicine of the Perelman School of Medicine, at the University of Pennsylvania in Philadelphia, PA. He is also the Co-Leader of the NCI designated Abramson Cancer Center Hematologic Malignancies Research Program and the Penn Medicine Hematologic Malignancies Translational Center of Excellence. He has been associated with the University for over 30 years. He has been the principal investigator of the Penn Core Center for the last 20 years of the NIH sponsored Blood and Marrow Clinical Trials Network and is the Chair of the steering committee.

Dr. Stadtmauer is widely published on the subjects of multiple myeloma, acute and chronic leukemia, and bone marrow transplantation and CAR T cell therapy. He has been appointed to the editorial boards of the Leukemia, Journal of Clinical Oncology and Bone Marrow Transplantation.  His works have appeared in such premier peer-reviewed journals as the New England Journal of Medicine, Journal of Clinical Oncology, Science, JAMA, Nature Medicine, Lancet Oncology, Science Translational Medicine and Blood.  His work has ranged from conducting the definitive study of autologous bone marrow transplant for breast cancer to pioneering clinical trials with cellular immunotherapy, CRISPR genetic engineering and vaccination for blood cancers.

Dr. Stadtmauer graduated with an AB degree with distinction in biochemistry from Cornell University and then completed his MD at the University of Pennsylvania School of Medicine. He served his internship and residency in internal medicine at the Albert Einstein College of Medicine in the Bronx, NY. He completed his Fellowship in Hematology/Oncology at the University of Pennsylvania where he co-founded the Bone Marrow Transplant Program in 1987 and the Myeloma Program in 1999. He has been awarded the DuPont Guerry, IV, MD Award for Outstanding Mentorship, University of Pennsylvania School of Medicine.